Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome

Author(s): Cheung AP

Abstract

Objective: To assess the role of endometrial thickness on vaginal ultrasound assessment and menstrual history in predicting endometrial hyperplasia in women with polycystic ovary syndrome (PCOS) who presented with infertility due to anovulation.

Methods: This was a prospective study in a university referral-based fertility and endocrine clinic. Fifty-six women with PCOS presenting with infertility due to anovulation underwent both vaginal ultrasound assessments and endometrial biopsies. The main outcome measures were the predictive value of sonographic endometrial thickness (primary objective) and the menstrual history with other clinical characteristics (secondary objective) for proliferative endometrium and endometrial hyperplasia in logistic regression analysis. Their predictive value was further examined by receiver operating characteristic curve analysis.

Results: Thirty-six PCOS patients (64.3%) had proliferative endometrium and 20 (35.7%) had endometrial hyperplasia. Five of the latter (25%) had cytologic atypia. Endometrial thickness less than 7 mm or intermenstrual interval less than 3 months (corresponding to more than four menstrual periods yearly) was associated with proliferative endometrium only. The endometrial thickness correlated positively with endometrial hyperplasia (P =.018) and, together with the average intermenstrual interval, were significant predictors of endometrial hyperplasia (P <.001).

Conclusion: These findings point to the usefulness of obtaining a detailed menstrual history in women with PCOS by identifying those at increased risk of endometrial hyperplasia and who require an endometrial biopsy. The endometrial thickness corroborates this clinical impression and is particularly useful when the menstrual history is uncertain. Endometrial hyperplasia in this population is effectively excluded when the endometrial thickness is less than 7 mm.

Similar Articles

Incidence of endometrial hyperplasia

Author(s): Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, et al.

Seromucinous Tumors of the Ovary

Author(s): Kurman RJ, Shih IeM

Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia

Author(s): Lacey JV Jr, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, et al.

Modifiable risk factors for cancer

Author(s): Stein CJ, Colditz GA

Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy

Author(s): Reed SD, Newton KM, Garcia RL, Allison KH, Voigt LF, et al.

Risk factors for endometrial hyperplasia: results from a case-control study

Author(s): Ricci E, Moroni S, Parazzini F, Surace M, Benzi G, et al.

High rate of endometrial hyperplasia in renal transplanted women

Author(s): Bobrowska K, Kamiński P, Cyganek A, Pietrzak B, Jabiry-Zieniewicz Z, et al.

Clinical parameters linked with malignancy in endometrial polyps

Author(s): Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N, et al.

Measuring inconsistency in meta-analyses

Author(s): Higgins JP, Thompson SG, Deeks JJ, Altman DG

Quantifying heterogeneity in a meta-analysis

Author(s): Higgins JP, Thompson SG

Bias in meta-analysis detected by a simple, graphical test

Author(s): Egger M, Davey Smith G, Schneider M, Minder C

Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women

Author(s): Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CF, et al.

Risk factors for adenomatous endometrial hyperplasia: a case-control study

Author(s): Kreiger N, Marrett LD, Clarke EA, Hilditch S, Woolever CA

Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy

Author(s): Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, et al.

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

Author(s): Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, et al.

Characteristics of women with a family history of ovarian cancer

Author(s): Cramer DW, Barbieri RL, Muto MG, Kelly A, Brucks JP, et al.

Cigarette smoking, relative weight, and menopause

Author(s): Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, et al.

Tobacco smoking and cancer: a meta-analysis

Author(s): Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, et al.

Smoking and colorectal cancer: a meta-analysis

Author(s): Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, et al.

An aggregated analysis of hormonal factors and endometrial cancer risk by parity

Author(s): Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, et al.

IUD use and the risk of endometrial cancer

Author(s): Benshushan A, Paltiel O, Rojansky N, Brzezinski A, Laufer N

Risk factors among young women with endometrial cancer: a Danish case-control study

Author(s): Parslov M, Lidegaard O, Klintorp S, Pedersen B, Jønsson L, et al.

A case-control study of cancer of the endometrium

Author(s): Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Mostow ED, et al.

Epidemiology of endometrial cancer

Author(s): Elwood JM, Cole P, Rothman KJ, Kaplan SD

Family history and the risk of endometrial cancer

Author(s): Parazzini F, La Vecchia C, Moroni S, Chatenoud L, Ricci E